Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Viracta Therapeutics, Inc. (VIRX) had Debt to Equity Ratio of 1.38 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-51.06M |
|
-- |
|
-- |
|
$50.69M |
|
$-50.69M |
|
$-0.36M |
|
$-51.06M |
|
$-51.06M |
|
$-51.06M |
|
$-51.06M |
|
$-51.06M |
|
$-51.06M |
|
$-50.69M |
|
$-52.26M |
|
38.62M |
|
38.62M |
|
$-1.32 |
|
$-1.32 |
|
| Balance Sheet Financials | |
$54.96M |
|
$0.19M |
|
$1.73M |
|
$56.69M |
|
$38.37M |
|
-- |
|
-- |
|
$38.37M |
|
$12.87M |
|
$18.32M |
|
$18.32M |
|
39.09M |
|
| Cash Flow Statement Financials | |
$-39.89M |
|
$15.00M |
|
$0.44M |
|
$36.77M |
|
$12.32M |
|
$-24.46M |
|
$7.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.43 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
1.38 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-40.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-396.81% |
|
-278.72% |
|
-90.06% |
|
-278.72% |
|
$0.47 |
|
$-1.04 |
|
$-1.03 |
|